These data indicate that rats uniquely recapitulate the predominant human phenotype—NOS ductal carcinoma that is ER+/PR+—and thus provide an urgently needed complement to mouse models for mechanistic studies of hormone-driven disease and for testing new therapeutics in prevention and treatment. This evidence concerns the gene PGR and breast ductal adenocarcinoma.